Article de revue

Economic implications of switching to the hexavalent infant vaccine in an immunization program in India

Combination vaccines can improve immunization coverage, timeliness, and acceptanceby reducing the number of injections and simplifying program delivery. The hexavalentvaccine, which combines the pentavalent vaccine with inactivated polio vaccine (IPV),has been adopted in several countries to maintain polio immunity while streamliningroutine immunization schedules. This study evaluates the economic implications ofintroducing the hexavalent vaccine into India’s national immunization program. Twointroduction scenarios were assessed: replacement of pentavalent and IPV, and replace-ment of pentavalent, IPV, and the Diphtheria-Tetanus-Pertussis (DTP) first booster. Theanalysis considered costs from both government provider and household perspectives,capturing changes in program costs as well as time savings for families associated withfewer vaccine administrations. The results indicate that introducing the hexavalentvaccine would increase overall program costs under both scenarios, driven primarilyby the higher price per dose of the hexavalent vaccine. However, the switch also yieldsoperational efficiencies and time savings for caregivers during immunization visits.Importantly, the findings show that price reductions substantially improve the economiccase for adoption. A 50% reduction in the unit price of the hexavalent vaccine wouldoffset the additional program costs in the first scenario, while further price reductionscould generate net cost savings in the second scenario. Overall, the study suggests thatadoption of the hexavalent vaccine in India could support more efficient and user-friendly immunization delivery. Achieving economic benefits, however, will dependcritically on procurement strategies that successfully lower vaccine prices.

Langues

  • Anglais

Année de publication

2026

Journal

HUMAN VACCINES & IMMUNOTHERAPEUTICS

Volume

22

Numéro

2026

Type

Article de revue

Catégories

  • Gestion de programme

Maladies

  • Diphtérie
  • Coqueluche
  • Polio
  • Tétanos

Pays

  • Inde

Mots-clés

  • Introduction de nouveaux vaccins
  • Planification, budgétisation et financement

Régions de l'OMS

  • Région de l'Asie du Sud-Est

PORTFOLIO-LESSONS

Cette ressource apparaît sur le Thème suivant:

Cette ressource est incluse dans le tableau suivant:

TitreAuteurAnnéeTypeLangue
The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questionsPATH2022ReportAnglais
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact AnalysisPATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health2021ReportRusse
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization ProgramPATH2020Case studyArabe, Anglais, Russe, Français
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI2019Case studyAnglais
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in ZambiaKirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass2020Journal articleAnglais
A Switch for Sustainability in Ghana's Rotavirus Vaccine ProgramGeorge Armah2020Case studyAnglais
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands HAPPI2025ReportAnglais
Economic implications of switching to the hexavalent infant vaccine in an immunization program in IndiaPawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari2026Journal articleAnglais

Ajouté par: Dr Kapil Kumar Singh

Ajouté le: 2026-06-28 14:25:13

Consultations: 299

Liens

Fichier téléchargé

Economic implications of switching to the hexavalent infant vaccine in an immunization program in India.pdf

Cliquez pour télécharger